Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors.
Journal: Journal for immunotherapy of cancer
Published: January 17, 2023
A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignancies.
Journal: Cancer chemotherapy and pharmacology
Published: April 03, 2021
Neoadjuvant Therapy for Melanoma: A U.S. Food and Drug Administration-Melanoma Research Alliance Public Workshop.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 19, 2020
A Machine-Learning Approach to Identify a Prognostic Cytokine Signature That Is Associated With Nivolumab Clearance in Patients With Advanced Melanoma.
Journal: Clinical pharmacology and therapeutics
Published: August 02, 2019
A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumors.
Journal: Cancer chemotherapy and pharmacology
Published: May 22, 2019
A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors.
Journal: Investigational new drugs
Published: March 08, 2019
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 23, 2018
Bone marrow tolerance during postoperative chemotherapy in colorectal carcinomas.
Journal: Journal of gastrointestinal oncology
Published: July 25, 2017
A Blueprint to Advance Colorectal Cancer Immunotherapies.
Journal: Cancer immunology research
Published: July 18, 2017
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study.
Journal: The Lancet. Oncology
Published: March 03, 2017
Neoadjuvant Chemotherapy and Adjuvant Chemoradiation Therapy in the Treatment of Resected Gastric Adenocarcinoma: A Case Series.
Journal: Case reports in oncology
Published: February 20, 2017
A Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination with Erlotinib in Patients with Advanced Solid Tumors.
Journal: The oncologist
Published: February 15, 2017
Last Updated: 09/26/2026